Susquehanna International Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.84M | Buy |
|
|||||
|
2025
Q2 | $1.6M | Buy |
|
|||||
|
2025
Q1 | $608K | Buy |
|
|||||
|
2024
Q4 | $923K | Buy |
|
|||||
|
2024
Q3 | $900K | Sell |
|
|||||
|
2024
Q2 | $1.18M | Buy |
|
|||||
|
2024
Q1 | $724K | Sell |
|
|||||
|
2023
Q4 | $2.78M | Buy |
|
|||||
|
2023
Q3 | $1.44M | Sell |
|
|||||
|
2023
Q2 | $5.15M | Buy |
|
|||||
|
2023
Q1 | $1.3M | Sell |
|
|||||
|
2022
Q4 | $970K | Sell |
|
|||||
|
2022
Q3 | $1.82M | Sell |
|
|||||
|
2022
Q2 | $2.21M | Buy |
|
|||||
|
2022
Q1 | $3.52M | Sell |
|
|||||
|
2021
Q4 | $7.43M | Buy |
|
|||||
|
2021
Q3 | $6.87M | Buy |
|
|||||
|
2021
Q2 | $3.69M | Buy |
|
|||||
|
2021
Q1 | $1.54M | Sell |
|
|||||
|
2020
Q4 | $7.1M | Sell |
|
|||||
|
2020
Q3 | $8.39M | Buy |
|
|||||
|
2020
Q2 | $4.6M | Sell |
|
|||||
|
2020
Q1 | $1.76M | Buy |
|
|||||
|
2019
Q4 | $969K | Sell |
|
|||||
|
2019
Q3 | $938K | Buy |
|
|||||
|
2019
Q2 | $388K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $178K | Buy |
|
|||||
|
2018
Q3 | $191K | Sell |
|
|||||
|
2018
Q2 | $224K | Buy |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $20K | Sell |
|
|||||
|
2017
Q1 | $31K | Sell |
|
|||||
|
2016
Q4 | $127K | Sell |
|
|||||
|
2016
Q3 | $220K | Buy |
|
|||||
|
2016
Q2 | $378K | Buy |
|
|||||
|
2016
Q1 | $255K | Sell |
|
|||||
|
2015
Q4 | $520K | Sell |
|
|||||
|
2015
Q3 | $585K | Sell |
|
|||||
|
2015
Q2 | $678K | Buy |
|
|||||
|
2015
Q1 | $357K | Sell |
|
|||||
|
2014
Q4 | $564K | Buy |
|
|||||
|
2014
Q3 | $543K | Buy |
|
|||||
|
2014
Q2 | – | Hold |
|